Hypogonadism Clinical Trials

2 recruiting

Frequently Asked Questions

Common questions about Hypogonadism clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting
Not Applicable

REMS25: Study on the Use of REMS Technology in Diseases Commonly Associated With Reduced Bone Mineral Density (BMD)

NeoplasiaOsteoporosisObesity, Overweight+6 more
Meyer Children's Hospital IRCCS100 enrolled1 locationNCT07412782
Recruiting

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Multiple Endocrine Neoplasia Type 1Multiple Endocrine Neoplasia Type 2Rare Disorders+337 more
Sanford Health20,000 enrolled2 locationsNCT01793168
Recruiting
Phase 3

Impact of Peri-operative tEstosterone Levels on oNcological and Functional Outcomes in RadiCal prostatEctomy

Prostatic NeoplasmsHypogonadismTestosterone Deficiency
Canisius-Wilhelmina Hospital140 enrolled10 locationsNCT04833426
Recruiting
Phase 2

Locomotor Training With Testosterone to Promote Bone and Muscle Health After Spinal Cord Injury

Central Nervous System DiseasesGenital Diseases, MaleHypogonadism+17 more
North Florida Foundation for Research and Education21 enrolled2 locationsNCT04460872
Recruiting

Fertility Enhancement Through Regenerative Treatment in Ovaries and Testes

Hypogonadism, MaleTestosterone DeficiencyGonadal Dysfunction+3 more
Jumeirah American Clinic60 enrolled1 locationNCT06841328
Recruiting
Phase 2

Testosterone Treatment in Men with Chronic Kidney Disease

Hypogonadism, MaleKidney Disease, Chronic
St. Louis University20 enrolled1 locationNCT05249634
Recruiting

ERectile Dysfunctions, gOnadotoxicity and Sexual Health Assessment in Men With Lung Cancer

NSCLC Stage IVSex DisorderHypogonadism, Male+1 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS80 enrolled1 locationNCT06532149
Recruiting

Genetics of Reproductive Disorders (Including Kallmann Syndrome) and Cleft Lip and/or Palate

Kallmann SyndromeHypogonadotropic HypogonadismHypothalamic Amenorrhea+5 more
Centre Hospitalier Universitaire Vaudois2,000 enrolled1 locationNCT01601171
Recruiting

Association Between Human Immunodeficiency Virus (HIV) Infection and Male Hypogonadism

Hypogonadism; Ovarian
National Taiwan University Hospital1,200 enrolled1 locationNCT04760574